CDK4/6 inhibitors in advanced breast cancer, what is beyond?

Faculty Medicine Year: 2019
Type of Publication: ZU Hosted Pages:
Authors:
Amarallah Abdelmoneim Mohamed Sayed
Journal: Oncology Reviews PAGEPress, Italy Volume:
Keywords : CDK4/6 inhibitors , advanced breast cancer, what    
Abstract:
Resistant to hormonal treatment considered the main clinical challenge in the management of advanced breast cancer (ABC). The use of CDK4/6 inhibitors (CDK4/6I) may change the treatment landscape. In this mandated review, we will focus on the applicable role of CDK4/6I in the management of HR+/HER2- ABC, mechanisms of resistance, and promising future implementation.
    
     
 
       

Author Related Publications

  • Amarallah Abdelmoneim Mohamed Sayed, "Myelodysplastic syndrome from theoretical review to clinical application view", PAGEPress, Italy, 2018 More
  • Amarallah Abdelmoneim Mohamed Sayed, "Patterns of Inpatient Admissions during Haj Clinical conditions, length of stay and patient outcomes at an advanced care centre in Makkah, Saudi Arabia", Pak J Med Sci, 2018 More
  • Amarallah Abdelmoneim Mohamed Sayed, "Neoadjuvant Platinum and Gemcitabine Regimens Precede Definitive Radiotherapy in Locally Advanced Bladder Cancer", Symbiosis, 2019 More
  • Amarallah Abdelmoneim Mohamed Sayed, "Efficacy and Safety of First-Line Pazopanib in Patients with Metastatic Renal Cell Carcinoma: Real-Life Multi Institutional Experience", Remedy Publications LLC, 2019 More
  • Amarallah Abdelmoneim Mohamed Sayed, "?Aggressive Care at the End of Life; Where Are We", Wolters Kluwer - Medknow, 2019 More

Department Related Publications

  • Amarallah Abdelmoneim Mohamed Sayed, "The pattern of infection and antibiotics use in terminal cancer patients", www.nci.cu.adu.eg www.sciencedirect.com, 2014 More
  • Tarek Ali Mohamed Elgohary, "The Impact of miRNA-155 Expression on Treatment Outcome in Adult Acute Myeloid Leukemia Patients. تأثير وجود (miRNA-155) على نتائج العلاج في مرضى سرطان الدم النقوي الحاد للبالغين", Journal of Cancer Therapy (2019) 10(3), 203-214, 2019 More
  • Rasha Mohamed Mostafa Hagag, "Impact of Prognostic Nutritional Index and Systemic Immune-Inflammation Index on the Clinical Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib", Zagazig University Medical Journal, 2022 More
  • Amarallah Abdelmoneim Mohamed Sayed, "Impact of cyclin D1 and DJ-1 on diagnosis, clinico-pathological features and outcome in prostate cancer and benign prostatic hyperplasia", Sciendo, 2019 More
  • Amarallah Abdelmoneim Mohamed Sayed, "Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: Correlation between Androgen Receptor Expression and Pathological Response", Asian Pac J Cancer Prev, 2020 More
Tweet